Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradeep Das

Showing results (231-240 of 318) with videos related to

Pageof 32
Sort By:
Therapeutics and Clinical Risk Management|May 14, 2009
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, IndiaVidya Nand Rabi Das, Niyamat Ali Siddiqui, Krishna Pandey, et al.
Journal of Cellular Biochemistry|May 19, 2018
Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasisAshish K Singh, Vidya N R Das, Ajay Amit, et al.
Epidemics|May 13, 2022
Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: an interrupted time series analysisVijay Kumar, Niyamat A Siddiqui, Timothy M Pollington, et al.
Molecular Immunology|January 9, 2017
Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c miceAjay Amit, Vijayamahantesh, Manas R Dikhit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2015
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in IndiaRaman Mahajan, Pradeep Das, Petros Isaakidis, et al.
Cytokine|March 22, 2017
Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans-membrane migration in association with CD2Pushkar Shivam, Sarita Kumari, Fauzia Jamal, et al.
The American Journal of Tropical Medicine and Hygiene|June 6, 2012
Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, IndiaVidya Nand Rabi Das, Alok Ranjan, Krishna Pandey, et al.
Plos Neglected Tropical Diseases|July 21, 2020
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, IndiaVishal Goyal, Vidya Nand Rabi Das, Shambhu Nath Singh, et al.
The American Journal of Tropical Medicine and Hygiene|September 25, 2020
False Positivity of rK39 Test in Five Chronic Myeloid Leukemia Cases from Bihar, India: A Possible Challenge to Leishmaniasis DiagnosisRoshan Kamal Topno, Major Madhukar, Krishna Pandey, et al.
Parasites & Vectors|June 25, 2017
Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgutSudha Verma, Sushmita Das, Abhishek Mandal, et al.
Pageof 32

Showing results (231-240 of 318) with videos related to

Sort By:
Pageof 32
Therapeutics and Clinical Risk Management|May 14, 2009
A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, IndiaVidya Nand Rabi Das, Niyamat Ali Siddiqui, Krishna Pandey, et al.
Journal of Cellular Biochemistry|May 19, 2018
Cytokines and chemokines differentially regulate innate immune cell trafficking during post kala-azar dermal leishmaniasisAshish K Singh, Vidya N R Das, Ajay Amit, et al.
Epidemics|May 13, 2022
Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: an interrupted time series analysisVijay Kumar, Niyamat A Siddiqui, Timothy M Pollington, et al.
Molecular Immunology|January 9, 2017
Immunization with Leishmania donovani protein disulfide isomerase DNA construct induces Th1 and Th17 dependent immune response and protection against experimental visceral leishmaniasis in Balb/c miceAjay Amit, Vijayamahantesh, Manas R Dikhit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2015
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in IndiaRaman Mahajan, Pradeep Das, Petros Isaakidis, et al.
Cytokine|March 22, 2017
Leishmania donovani resistant to Ambisome or Miltefosine exacerbates CD58 expression on NK cells and promotes trans-membrane migration in association with CD2Pushkar Shivam, Sarita Kumari, Fauzia Jamal, et al.
The American Journal of Tropical Medicine and Hygiene|June 6, 2012
Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, IndiaVidya Nand Rabi Das, Alok Ranjan, Krishna Pandey, et al.
Plos Neglected Tropical Diseases|July 21, 2020
Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, IndiaVishal Goyal, Vidya Nand Rabi Das, Shambhu Nath Singh, et al.
The American Journal of Tropical Medicine and Hygiene|September 25, 2020
False Positivity of rK39 Test in Five Chronic Myeloid Leukemia Cases from Bihar, India: A Possible Challenge to Leishmaniasis DiagnosisRoshan Kamal Topno, Major Madhukar, Krishna Pandey, et al.
Parasites & Vectors|June 25, 2017
Role of inhibitors of serine peptidases in protecting Leishmania donovani against the hydrolytic peptidases of sand fly midgutSudha Verma, Sushmita Das, Abhishek Mandal, et al.
Pageof 32